Pergolide (trade names Permax, Prascend) is an ergoline-based dopamine
receptor agonist used in some countries for the treatment of Parkinson's disease.
What is Pergolide? Pergolide (pergolide mesylate) controls the output of a
hormone called ACTH. If ACTH is not controlled, the pituitary tumor grows
Easy to read patient leaflet for pergolide mesylate. Includes indications, proper
use, special instructions, precautions, and possible side effects.
Dec 8, 2004 ... Learn about the prescription medication Permax (Pergolide Mesylate), drug uses,
dosage, side effects, drug interactions, warnings, reviews ...
Prascend® (pergolide mesylate) is the only FDA-approved formulation of
pergolide mesylate on the market approved for use in horses. PRASCEND is the
Jun 13, 2005 ... Pergolide is a long-acting dopamine agonist approved in 1982 for the treatment
of Parkinson's Disease. It is an ergot derivative that acts on the ...
Note: Pergolide in cookies is not the best option. The cookies are made of oats
and molasses which are Insulin Resistance triggers. Many Pergolide syrups have
Mar 3, 2016 ... Issued: April 20, 2012. Reissued: March 2, 2016. Dear Equine Veterinarian: In
September 2011, FDA approved PRASCEND (pergolide ...
Aug 15, 2013 ... The drug is also known and marketed by its generic name pergolide [per-go-lide].
I am Pat Clarke from F-D-A's Center for Drug Evaluation and ...
Jul 17, 2015 ... FDA today announces that manufacturers of pergolide drug products, which are
used to treat Parkinson's disease, will voluntarily remove these ...